Fig. 2.
MSH2 and MLH1 immunohistochemistry in MSI+ ATLLs. Expressions of MSH2 and MLH1 in the MSI+ tumours were examined by immunohistochemistry using three independent antibodies. Representative results are shown (patient ATL01 and ATL16). No abnormal expression of these proteins was observed in all MSI+ ATLLs